Cagrilintide — ZPHC Pro-Line
5 lyophilised vials × 5 mg (total 25 mg) + sterile diluent
- Amylin receptor analogue: researched for potent appetite suppression and reduced caloric intake.
- Satiety & gastric emptying: enhances fullness signals and slows gastric emptying for improved weight-management outcomes.
- High-purity formulation: ≥ 98.9% purity (HPLC); produced under GMP & ISO 17034:2016 standards with ZPHC scratch-code verification.
- Reconstitution: combine with sterile diluent provided; swirl gently until dissolved. Store at 2–8 °C.
- For research use only: analytical reference material; not intended for therapeutic or human use.
- Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery.
⚗️ Handling & Storage
-
Store lyophilized powder in a cool, dry place
-
After reconstitution, refrigerate at 2–8 °C (do not freeze)
-
For research use only — not approved for human consumption
Parameter Standard Range Notes Dose 0.3–1.8 mg per injection Adjusted based on study design Frequency Daily Supports steady peptide activity Cycle Length 4–12 weeks Often followed by off‑cycle period Administration Subcutaneous injection after reconstitution Allows controlled peptide delivery Timing Morning or pre‑meal Aligns with natural appetite regulation cycles
-
